182 related articles for article (PubMed ID: 12241106)
1. Subcellular biodistribution of sodium borocaptate (BSH: Na2B12H11SH) in a rat glioma model in boron neutron capture therapy.
Kageji T; Nagahiro S; Otersen B; Gabel D; Nakaichi M; Nakagawa Y
J Neurooncol; 2002 Sep; 59(2):135-42. PubMed ID: 12241106
[TBL] [Abstract][Full Text] [Related]
2. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
5. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma.
Kageji T; Nagahiro S; Kitamura K; Nakagawa Y; Hatanaka H; Haritz D; Grochulla F; Haselsberger K; Gabel D
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):120-30. PubMed ID: 11516861
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
7. Binding and distribution of Na2B12H11SH on cellular and subcellular level in tumor tissue of glioma patients in boron neutron capture therapy.
Otersen B; Haritz D; Grochulla F; Bergmann M; Sierralta W; Gabel D
J Neurooncol; 1997 May; 33(1-2):131-9. PubMed ID: 9151230
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy.
Doi A; Kawabata S; Iida K; Yokoyama K; Kajimoto Y; Kuroiwa T; Shirakawa T; Kirihata M; Kasaoka S; Maruyama K; Kumada H; Sakurai Y; Masunaga S; Ono K; Miyatake S
J Neurooncol; 2008 May; 87(3):287-94. PubMed ID: 18219552
[TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy of brain tumors: functional and neuropathologic effects of blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
Yang W; Barth RF; Rotaru JH; Boesel CP; Wilkie DA; Bresnahan JC; Hadjiconstantinou M; Goettl VM; Joel DD; Nawrocky MM
J Neurooncol; 2000 Jul; 48(3):179-90. PubMed ID: 11100816
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas.
Goodman JH; Yang W; Barth RF; Gao Z; Boesel CP; Staubus AE; Gupta N; Gahbauer RA; Adams DM; Gibson CR; Ferketich AK; Moeschberger ML; Soloway AH; Carpenter DE; Albertson BJ; Bauer WF; Zhang MZ; Wang CC
Neurosurgery; 2000 Sep; 47(3):608-21; discussion 621-2. PubMed ID: 10981748
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT.
Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Asano T; Kirihata M; Ono K; Kuroiwa T
J Neurooncol; 2006 Jul; 78(3):227-32. PubMed ID: 16557351
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors.
Kageji T; Nakagawa Y; Kitamura K; Matsumoto K; Hatanaka H
J Neurooncol; 1997 May; 33(1-2):117-30. PubMed ID: 9151229
[TBL] [Abstract][Full Text] [Related]
13. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
[No Abstract] [Full Text] [Related]
14. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model.
Suzuki M; Masunaga S; Kinashi Y; Nagata K; Sakurai Y; Nakamatsu K; Nishimura Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):260-6. PubMed ID: 15093923
[TBL] [Abstract][Full Text] [Related]
15. A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and sulfhydryl boron hydride (BSH) in the RG2 rat glioma model.
Ceberg CP; Brun A; Kahl SB; Koo MS; Persson BR; Salford LG
J Neurosurg; 1995 Jul; 83(1):86-92. PubMed ID: 7782856
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of sodium borocaptate: a critical assessment of dosing paradigms for boron neutron capture therapy.
Gibson CR; Staubus AE; Barth RF; Yang W; Ferketich AK; Moeschberger MM
J Neurooncol; 2003; 62(1-2):157-69. PubMed ID: 12749711
[TBL] [Abstract][Full Text] [Related]
17. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
18. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT).
Haritz D; Gabel D; Huiskamp R
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1175-81. PubMed ID: 8175403
[TBL] [Abstract][Full Text] [Related]
19. Cell culture and animal studies for intracerebral delivery of borocaptate in liposomal formulation.
Ji B; Chen W; Lu DR; Halpern DS
Drug Deliv; 2001; 8(1):13-7. PubMed ID: 11280438
[TBL] [Abstract][Full Text] [Related]
20. Enhanced boron uptake in RG 2 rat gliomas by electropermeabilization in vivo--a new possibility in boron neutron capture therapy.
Ceberg CP; Brun A; Mir LM; Persson BR; Salford LG
Anticancer Drugs; 1994 Aug; 5(4):463-6. PubMed ID: 7949252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]